CD44v6 as a prognostic factor in cervical carcinoma FIGO stage IB

Abstrakt

One hundred and seventy-eight patients and FIGO IB cervical carcinoma (142 IB N0, 36 IB N1) and adequate surgical staging, with a follow-up of at least 5 years, were included in the study. The median age of the patients was 40.5 years.